Understanding Endophthalmitis: Symptoms, diagnosis, and treatment of this serious intraocular infection. This resource provides information on Endophthalmitis (ICD-10 H44.0), including clinical documentation, medical coding, and healthcare best practices for purulent endophthalmitis and other forms of intraocular infection. Learn about the causes, risk factors, and available treatments for Endophthalmitis.
Also known as
Endophthalmitis
Inflammation of the internal eye structures.
Diseases of the eye and adnexa
Covers various eye conditions, including infections and inflammatory disorders.
Bacterial, viral and other infectious agents
Classifies infectious agents that may cause eye infections like endophthalmitis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the endophthalmitis post-procedural?
When to use each related code
| Description |
|---|
| Severe eye infection, often after surgery or trauma. |
| Eye inflammation, not primarily infectious. |
| Infection around the eye, not inside. |
Missing or incorrect laterality (right, left, bilateral) for Endophthalmitis can lead to inaccurate claims and denials.
Failing to document the causative organism (e.g., bacterial, fungal) impacts coding specificity and infection tracking.
Distinguishing between postoperative Endophthalmitis and exogenous Endophthalmitis is crucial for appropriate coding and quality metrics.
Q: What are the most effective evidence-based antibiotic treatment protocols for acute postoperative endophthalmitis following cataract surgery?
A: Acute postoperative endophthalmitis following cataract surgery requires prompt and aggressive intervention. The current standard of care, based on the Endophthalmitis Vitrectomy Study (EVS), involves intravitreal injection of vancomycin and ceftazidime. However, more recent studies have investigated the use of moxifloxacin and amikacin, particularly for gram-negative coverage. The choice of antibiotics should be guided by local resistance patterns and patient-specific factors, such as allergies and previous exposure to antibiotics. Culture and sensitivity testing of vitreous samples are crucial for tailoring subsequent therapy. Consider implementing a standardized protocol for managing postoperative endophthalmitis in your practice to ensure consistent and timely intervention. Explore how S10.AI can assist in creating and tracking adherence to such protocols.
Q: How do I differentiate between infectious and sterile endophthalmitis in a patient presenting with post-injection inflammation, and what are the key clinical features that distinguish them?
A: Differentiating between infectious endophthalmitis and sterile post-injection inflammation can be challenging. Infectious endophthalmitis typically presents with significant pain, marked vision loss, hypopyon, and vitritis. Sterile inflammation usually involves less severe pain, milder visual impairment, and predominantly anterior chamber inflammation. Key clinical features to consider include the timing of onset (infectious endophthalmitis tends to appear earlier), the severity of symptoms, and the presence of hypopyon or vitritis. A thorough history, including details of the injection procedure and any predisposing factors, is essential. Consider implementing a standardized post-injection follow-up protocol that incorporates dilated fundus examination and optical coherence tomography (OCT) to aid in early diagnosis and prompt management. Learn more about the latest advancements in OCT imaging for detecting endophthalmitis.
Patient presents with signs and symptoms consistent with endophthalmitis, an intraocular infection. Onset of [acute/subacute/chronic] ocular pain, redness (conjunctival injection), photophobia, and decreased visual acuity was reported as [onset timeframe and description]. Examination revealed [describe findings: e.g., hypopyon, vitritis, chemosis, corneal edema, anterior chamber cells/flare]. Differential diagnosis includes uveitis, panophthalmitis, and orbital cellulitis. Given the clinical presentation and findings, a diagnosis of endophthalmitis (purulent endophthalmitis) is suspected. [Specify if exogenous or endogenous endophthalmitis is suspected, and provide rationale]. Visual acuity in the affected eye is [record visual acuity]. [Document prior ocular surgery, trauma, or systemic infections if applicable]. Patient was informed of the diagnosis and risks of vision loss. Treatment plan includes [specify treatment, e.g., intravitreal antibiotic injection, pars plana vitrectomy, systemic antibiotics]. Patient will return for follow-up in [timeframe] to monitor response to therapy and assess for complications such as retinal detachment or phthisis bulbi. ICD-10 code H44.0 will be used for billing purposes. This documentation supports medical necessity for the procedures and treatments provided.